首页> 美国卫生研究院文献>Journal of Experimental Clinical Cancer Research : CR >Overexpressed ITGA2 promotes malignant tumor aggression by up-regulating PD-L1 expression through the activation of the STAT3 signaling pathway
【2h】

Overexpressed ITGA2 promotes malignant tumor aggression by up-regulating PD-L1 expression through the activation of the STAT3 signaling pathway

机译:过表达的ITGA2通过激活STAT3信号通路来上调PD-L1表达从而促进恶性肿瘤侵袭

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The overexpression of ITGA2 is correlated with unfavorable prognosis in malignant tumors. . ITGA2 mRNA expression level determined by the GEPIA web tool. The boxplot analysis showed the expression level by log2 (TPM + 1) on a log-scale. ns, not significant; *,  b. IHC Images of ITGA2 staining using TMA tissue sections. The scale bars were shown in the figure. . Dot plots to show the IHC score of ITGA2 expression using TMA tissue sections (normal pancreatic specimens:  = 25, PDAC TMA specimens:  = 31,  d and . Western blot analysis for the expression of ITGA2 in 12 paired primary PDAC tissues (T) and the matched adjacent normal tissues (ANT) of the same patient (d). The proteins expression level of ITGA2 were quantified by ImageJ software (e). GAPDH served as an internal reference. The values were also shown. Statistical analyses were performed with D’Agostino & Pearson omnibus normality test. and . GEPIA web tool was searched for the overall survival (f,  = 0.015, HR = 2.0) and disease-free survival ( ,  = 0.039, HR = 1.9) of PDAC patients. . The Human Protein Atlas database was searched for the overall survival of PDAC patients (
机译:ITGA2的过表达与恶性肿瘤预后不良有关。 。由GEPIA网络工具确定的ITGA2 mRNA表达水平。箱线图分析以对数刻度显示了log2(TPM + 1)的表达水平。 ns,不重要; *,b。使用TMA组织切片对ITGA2染色的IHC图像。比例尺如图所示。 。点图显示使用TMA组织切片ITGA2表达的IHC得分(正常胰腺标本:= 25,PDAC TMA标本:= 31,d和。Western blot分析ITGA2在12对配对的原发PDAC组织(T)和同一患者的匹配的相邻正常组织(ANT)(d),通过ImageJ软件(e)定量ITGA2的蛋白表达水平,以GAPDH作为内部参考,并显示了这些值,并用D进行统计分析搜索了'Agostino&Pearson的综合正常性测试和GEPIA网络工具,以了解PDAC患者的总体生存率(f,= 0.015,HR = 2.0)和无病生存期(= 0.039,HR = 1.9)。在Protein Atlas数据库中搜索了PDAC患者的总体生存情况(

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号